propionyl-l-carnitine peyronie's disease Full article: Current status and new developments in disease: medical, minimally invasive and surgical treatment options Peyronie's Disease Treatment: Proven Solutions
Description
+ ( )
10.1016/j.celrep.2014.12.036
10.1053/siny.2002.0097 86 RoscaM
Nrf2 is a transcriptional target of PGC1 and Nrf2 which promotes mitochondrial biogenesis [45]
Rebouche CJ, Seim H: Carnitine metabolism and its regulation in microorganisms and mammals
